Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo

Journal: Nature

Published: 2020-01-22

DOI: 10.1038/s41586-020-1951-3

Affiliations: 19

Authors: 43

Go to article
Institutions Share
Emory Yerkes National Primate Research Center, United States of America (USA) 0.15
UNC Center for AIDS Research (CFAR), United States of America (USA) 0.12
UNC Division of Infectious Diseases, United States of America (USA) 0.12
Department of Pediatrics, Emory University, United States of America (USA) 0.10
GlaxoSmithKline R&D Collegeville, United States of America (USA) 0.08
Qura Therapeutics, United States of America (USA) 0.08
UNC Translational and Clinical Sciences (NC TraCS) Institute, United States of America (USA) 0.08
AIDS and Cancer Virus Program (ACVP), FNLCR, United States of America (USA) 0.07
ViiV Healthcare Company USA, United States of America (USA) 0.05
UNC HIV Cure Center, United States of America (USA) 0.04
McGill University Health Centre (MUHC), Canada 0.02
Department of Pathology and Laboratory Medicine, Emory University, United States of America (USA) 0.02
UNC Department of Genetics, United States of America (USA) 0.02
UNC Department of Biology, United States of America (USA) 0.02
UNC Department of Microbiology and Immunology, United States of America (USA) 0.01
Center for Childhood Infections and Vaccines (CCIV), United States of America (USA) 0.01
Guangzhou Eighth People's Hospital, GMU, China 0.01
UNC Department of Epidemiology, United States of America (USA) 0

Return